Use of ClearPoint System to Place Laser Ablation Catheters Will Also be Discussed in a Scientific Presentation
IRVINE, Calif. - MRI Interventions, Inc. (OTCQB:MRIC), a commercial stage medical technology company focused on creating innovative platforms for performing the next generation of minimally invasive surgical procedures in the brain and heart, today announced that it will be exhibiting its ClearPoint® Neuro Intervention System at the 2014 American Society for Stereotactic and Functional Neurosurgery (ASSFN) Biennial Meeting to be held June 1-3 in Washington, D.C.
The ClearPoint system's role in enabling real-time MR-guided neurosurgical procedures will also be discussed in scientific sessions.
-- On Monday, June 2, Dr. Robert Gross, neurosurgeon at Emory University
Hospital, will present "Laser Ablation for Epilepsy," which will include
a description of the ClearPoint system's critical role in the targeting
and placement of laser ablation catheters under real-time MRI guidance.
-- On Tuesday, June 3, Dr. Karl Sillay, neurosurgeon at University of
Wisconsin (UW) Hospitals and Clinics, will give a talk titled
"Neurosurgery in the MR Suite" that will include a description of UW
Hospitals and Clinics' utilization of the ClearPoint system for
According to the ASSFN, its Biennial Meeting "is dedicated to the rapidly growing specialty of stereotactic and functional neurosurgery. The meeting emphasizes cutting-edge clinical applications and recent discoveries in the basic neurosciences and the impact they will have on future advances in stereotactic and functional neurosurgery."
About MRI Interventions, Inc.
Founded in 1998, MRI Interventions is creating innovative platforms for performing the next generation of minimally invasive surgical procedures in the brain and heart. Utilizing a hospital's existing MRI suite, the company's FDA-cleared and CE-marked ClearPoint® system is designed to enable a range of minimally invasive procedures in the brain. In partnership with Siemens Healthcare, MRI Interventions is developing the ClearTrace® system to enable MRI-guided catheter ablations to treat cardiac arrhythmias, including atrial fibrillation. Building on the imaging power of MRI, the company's interventional platforms strive to improve patient care while reducing procedure costs and times. For more information, please visit www.mriinterventions.com.
MRI Interventions, Inc.
David Carlson, CFO